Artelo Biosciences Stock Price Prediction
| ARTL Stock | USD 1.31 0.01 0.77% |
Oversold Vs Overbought
58
Oversold | Overbought |
Artelo Biosciences stock price prediction is an act of determining the future value of Artelo Biosciences shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Artelo Biosciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Artelo Biosciences and does not consider all of the tangible or intangible factors available from Artelo Biosciences' fundamental data. We analyze noise-free headlines and recent hype associated with Artelo Biosciences, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Artelo Biosciences' stock price prediction:EPS Estimate Next Quarter (0.53) | EPS Estimate Current Year (2.56) | EPS Estimate Next Year (1.04) | Wall Street Target Price 16.67 | EPS Estimate Current Quarter (0.65) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Artelo Biosciences based on different types of headlines from major news networks to social media. The Artelo stock price prediction module provides an analysis of price elasticity to changes in media outlook on Artelo Biosciences over a specific investment horizon. Using Artelo Biosciences hype-based prediction, you can estimate the value of Artelo Biosciences from the perspective of Artelo Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Artelo Biosciences. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Artelo Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Artelo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Artelo Biosciences after-hype prediction price | USD 1.3 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Artelo |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Artelo Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Artelo Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Artelo Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Artelo Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Artelo Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Artelo Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Artelo Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Artelo Biosciences' historical news coverage. Artelo Biosciences' after-hype downside and upside margins for the prediction period are 0.07 and 4.63, respectively. We have considered Artelo Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Artelo Biosciences is slightly risky at this time. Analysis and calculation of next after-hype price of Artelo Biosciences is based on 3 months time horizon.
Artelo Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Artelo Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Artelo Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Artelo Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 3.30 | 0.00 | 0.00 | 6 Events / Month | 3 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.31 | 1.30 | 0.00 |
|
Artelo Biosciences Hype Timeline
Artelo Biosciences is presently traded for 1.31. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Artelo is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.01%. %. The volatility of related hype on Artelo Biosciences is about 4258.06%, with the expected price after the next announcement by competition of 1.31. The company has price-to-book (P/B) ratio of 0.42. Some equities with similar Price to Book (P/B) outperform the market in the long run. Artelo Biosciences recorded a loss per share of 3.14. The entity last dividend was issued on the 21st of June 2019. The firm had 1:15 split on the 10th of August 2022. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days. Check out Artelo Biosciences Basic Forecasting Models to cross-verify your projections.Artelo Biosciences Related Hype Analysis
Having access to credible news sources related to Artelo Biosciences' direct competition is more important than ever and may enhance your ability to predict Artelo Biosciences' future price movements. Getting to know how Artelo Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Artelo Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SSIC | Silver Spike Investment | (0.32) | 9 per month | 1.32 | 0.20 | 4.64 | (2.50) | 11.33 | |
| ALKS | Alkermes Plc | 0.36 | 10 per month | 0.00 | (0.09) | 2.79 | (4.24) | 21.89 | |
| EGRX | Eagle Pharmaceuticals | (0.40) | 10 per month | 4.81 | 0.01 | 8.00 | (7.92) | 23.10 | |
| EVO | Evotec SE ADR | 0.05 | 3 per month | 0.00 | (0.07) | 4.10 | (4.16) | 13.79 |
Artelo Biosciences Additional Predictive Modules
Most predictive techniques to examine Artelo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Artelo using various technical indicators. When you analyze Artelo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Artelo Biosciences Predictive Indicators
The successful prediction of Artelo Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Artelo Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Artelo Biosciences based on analysis of Artelo Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Artelo Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Artelo Biosciences's related companies. | 2019 | 2020 | 2021 | 2023 (projected) | Net Debt To EBITDA | 0.45 | 0.88 | 0.66 | 0.76 | Intangibles To Total Assets | 0.47 | 0.16 | 0.0998 | 0.11 |
Story Coverage note for Artelo Biosciences
The number of cover stories for Artelo Biosciences depends on current market conditions and Artelo Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Artelo Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Artelo Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Artelo Biosciences Short Properties
Artelo Biosciences' future price predictability will typically decrease when Artelo Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Artelo Biosciences often depends not only on the future outlook of the potential Artelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Artelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.8 M | |
| Cash And Short Term Investments | 17.5 M |
Check out Artelo Biosciences Basic Forecasting Models to cross-verify your projections. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Artelo Stock analysis
When running Artelo Biosciences' price analysis, check to measure Artelo Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artelo Biosciences is operating at the current time. Most of Artelo Biosciences' value examination focuses on studying past and present price action to predict the probability of Artelo Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artelo Biosciences' price. Additionally, you may evaluate how the addition of Artelo Biosciences to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Artelo Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Return On Assets (0.37) | Return On Equity (0.60) |
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.